wall street stocks/marion labs &lt;mkc> marion laboratories inc's stock rose sharply today company presented bullish earnings scenario meeting pharmaceutical analysts monday, traders analysts said. company expects earnings fiscal 1987, ending june 30, rise 75 pct year ago. pronouncement encouraged analyst david crossen sanford c. bernstein raise earnings estimates company 1.28 dlrs share 1987, compared previous estimate 1.20 dlrs share. year company earned 70 cts share. marion's stock gained 3-1/4 75-1/2. meeting pharmaceutical analysts, marion's president fred lyons jr. wall street eanrings estimates 1.10-1.15 dlrs share fiscal 1987 "are expected aggressive side range 10 15 cts low." lyons strong performance half year result fourth quarter introduction 90 mg 120 mg cardizem tablets. analyst crossen cardizem, treats angina, expected approved treatment hypertension end year. crossen "because marion small company, growth cardizem big impact bottom line." raised fiscal 1988 earnings estimates 2.15 dlrs share previous estimate 2.05 dlrs share. "the company broad product pipeline industry concerned, innovative company business," said. years 1991, crossen expects marion growth rate 55 pct.